Encompass Health Corp (EHC) - Net Assets
Based on the latest financial reports, Encompass Health Corp (EHC) has net assets worth $3.37 Billion USD as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($7.31 Billion) and total liabilities ($3.95 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check EHC tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.37 Billion |
| % of Total Assets | 46.04% |
| Annual Growth Rate | N/A |
| 5-Year Change | 36.54% |
| 10-Year Change | 207.01% |
| Growth Volatility | 64.28 |
Encompass Health Corp - Net Assets Trend (1985–2025)
This chart illustrates how Encompass Health Corp's net assets have evolved over time, based on quarterly financial data. See operational self-sufficiency of Encompass Health Corp to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Encompass Health Corp (1985–2025)
The table below shows the annual net assets of Encompass Health Corp from 1985 to 2025. For live valuation and market cap data, see Encompass Health Corp (EHC) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | $3.28 Billion | +14.97% |
| 2024-12-31 | $2.85 Billion | +24.03% |
| 2023-12-31 | $2.30 Billion | +23.38% |
| 2022-12-31 | $1.86 Billion | -22.39% |
| 2021-12-31 | $2.40 Billion | +19.86% |
| 2020-12-31 | $2.00 Billion | +3.56% |
| 2019-12-31 | $1.93 Billion | +3.29% |
| 2018-12-31 | $1.87 Billion | +13.71% |
| 2017-12-31 | $1.65 Billion | +54.22% |
| 2016-12-31 | $1.07 Billion | +18.50% |
| 2015-12-31 | $900.40 Million | +12.92% |
| 2014-12-31 | $797.40 Million | +38.58% |
| 2013-12-31 | $575.40 Million | -22.90% |
| 2012-12-31 | $746.30 Million | +270.19% |
| 2011-12-31 | $201.60 Million | +9263.64% |
| 2010-12-31 | $-2.20 Million | +99.75% |
| 2009-12-31 | $-897.60 Million | +17.44% |
| 2008-12-31 | $-1.09 Billion | +25.40% |
| 2007-12-31 | $-1.46 Billion | +23.84% |
| 2006-12-31 | $-1.91 Billion | -51.03% |
| 2005-12-31 | $-1.27 Billion | -71.80% |
| 2004-12-31 | $-737.46 Million | 0.00% |
| 2003-12-31 | $-737.46 Million | -39.46% |
| 2002-12-31 | $-528.80 Million | -113.38% |
| 2001-12-31 | $3.95 Billion | +7.83% |
| 2000-12-31 | $3.66 Billion | +9.95% |
| 1999-12-31 | $3.33 Billion | -6.13% |
| 1998-12-31 | $3.55 Billion | +9.20% |
| 1997-12-31 | $3.25 Billion | +105.09% |
| 1996-12-31 | $1.59 Billion | +67.13% |
| 1995-12-31 | $948.45 Million | +123.73% |
| 1994-12-31 | $423.93 Million | +44.59% |
| 1993-12-31 | $293.20 Million | +1.91% |
| 1992-12-31 | $287.70 Million | +3.04% |
| 1991-12-31 | $279.20 Million | +116.43% |
| 1990-12-31 | $129.00 Million | +90.83% |
| 1989-12-31 | $67.60 Million | +17.98% |
| 1988-12-31 | $57.30 Million | +11.70% |
| 1987-12-31 | $51.30 Million | +106.85% |
| 1986-12-31 | $24.80 Million | +1227.27% |
| 1985-12-31 | $-2.20 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Encompass Health Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 129180000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $1.29 Billion | 52.88% |
| Common Stock | $1.20 Million | 0.05% |
| Other Comprehensive Income | $500.00K | 0.02% |
| Other Components | $1.15 Billion | 47.05% |
| Total Equity | $2.44 Billion | 100.00% |
Encompass Health Corp Competitors by Market Cap
The table below lists competitors of Encompass Health Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Suzano S.A.
SA:SUZB3
|
$10.07 Billion |
|
Deutsche Lufthansa AG
F:LHAB
|
$10.07 Billion |
|
Fervo Energy Company Class A common stock
NASDAQ:FRVO
|
$10.07 Billion |
|
Prada S.p.A.
F:PRP
|
$10.08 Billion |
|
Federal Realty Investment Trust
NYSE:FRT
|
$10.05 Billion |
|
Hecla Mining Company
NYSE:HL
|
$10.05 Billion |
|
CPFL Energia S.A
SA:CPFE3
|
$10.04 Billion |
|
CSPC Pharmaceutical Group Limited
F:CVG
|
$10.04 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Encompass Health Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 2,067,000,000 to 2,438,200,000, a change of 371,200,000 (18.0%).
- Net income of 566,200,000 contributed positively to equity growth.
- Dividend payments of 71,100,000 reduced retained earnings.
- Share repurchases of 158,000,000 reduced equity.
- Other comprehensive income increased equity by 500,000.
- Other factors increased equity by 33,600,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $566.20 Million | +23.22% |
| Dividends Paid | $71.10 Million | -2.92% |
| Share Repurchases | $158.00 Million | -6.48% |
| Other Comprehensive Income | $500.00K | +0.02% |
| Other Changes | $33.60 Million | +1.38% |
| Total Change | $- | 17.96% |
Book Value vs Market Value Analysis
This analysis compares Encompass Health Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 4.25x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $-0.08 | $101.47 | x |
| 1986-12-31 | $0.87 | $101.47 | x |
| 1987-12-31 | $1.80 | $101.47 | x |
| 1988-12-31 | $2.01 | $101.47 | x |
| 1989-12-31 | $2.32 | $101.47 | x |
| 1990-12-31 | $4.50 | $101.47 | x |
| 1991-12-31 | $9.82 | $101.47 | x |
| 1992-12-31 | $10.20 | $101.47 | x |
| 1993-12-31 | $10.37 | $101.47 | x |
| 1994-12-31 | $13.91 | $101.47 | x |
| 1995-12-31 | $15.21 | $101.47 | x |
| 1996-12-31 | $23.05 | $101.47 | x |
| 1997-12-31 | $39.64 | $101.47 | x |
| 1998-12-31 | $39.59 | $101.47 | x |
| 1999-12-31 | $38.67 | $101.47 | x |
| 2000-12-31 | $45.05 | $101.47 | x |
| 2001-12-31 | $45.73 | $101.47 | x |
| 2002-12-31 | $-6.47 | $101.47 | x |
| 2003-12-31 | $-9.09 | $101.47 | x |
| 2004-12-31 | $-11.87 | $101.47 | x |
| 2005-12-31 | $-19.36 | $101.47 | x |
| 2006-12-31 | $-24.19 | $101.47 | x |
| 2007-12-31 | $-16.90 | $101.47 | x |
| 2008-12-31 | $-12.13 | $101.47 | x |
| 2009-12-31 | $-9.43 | $101.47 | x |
| 2010-12-31 | $-0.79 | $101.47 | x |
| 2011-12-31 | $1.07 | $101.47 | x |
| 2012-12-31 | $5.86 | $101.47 | x |
| 2013-12-31 | $4.29 | $101.47 | x |
| 2014-12-31 | $5.62 | $101.47 | x |
| 2015-12-31 | $6.05 | $101.47 | x |
| 2016-12-31 | $7.40 | $101.47 | x |
| 2017-12-31 | $11.90 | $101.47 | x |
| 2018-12-31 | $13.32 | $101.47 | x |
| 2019-12-31 | $13.60 | $101.47 | x |
| 2020-12-31 | $15.91 | $101.47 | x |
| 2021-12-31 | $19.07 | $101.47 | x |
| 2022-12-31 | $13.05 | $101.47 | x |
| 2023-12-31 | $16.26 | $101.47 | x |
| 2024-12-31 | $20.23 | $101.47 | x |
| 2025-12-31 | $23.86 | $101.47 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Encompass Health Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.22%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.54%
- • Asset Turnover: 0.84x
- • Equity Multiplier: 2.91x
- Recent ROE (23.22%) is above the historical average (16.59%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 0.00% | -33.33% | 0.33x | 0.00x | $-1.28 Million |
| 1986 | 2.02% | 2.69% | 0.36x | 2.09x | $-1.98 Million |
| 1987 | 7.41% | 8.44% | 0.45x | 1.94x | $-1.33 Million |
| 1988 | 9.95% | 7.60% | 0.56x | 2.34x | $-30.00K |
| 1989 | 12.29% | 7.09% | 0.52x | 3.32x | $1.51 Million |
| 1990 | 10.09% | 7.15% | 0.60x | 2.35x | $110.00K |
| 1991 | 8.02% | 9.93% | 0.48x | 1.69x | $-5.53 Million |
| 1992 | 10.24% | 7.30% | 0.63x | 2.21x | $690.00K |
| 1993 | 2.27% | 1.39% | 0.41x | 3.96x | $-22.80 Million |
| 1994 | 12.49% | 4.72% | 0.73x | 3.64x | $10.61 Million |
| 1995 | 10.59% | 4.63% | 0.86x | 2.65x | $5.43 Million |
| 1996 | 12.98% | 7.43% | 0.79x | 2.22x | $45.21 Million |
| 1997 | 10.87% | 10.99% | 0.58x | 1.71x | $27.36 Million |
| 1998 | 1.36% | 1.16% | 0.59x | 1.98x | $-295.74 Million |
| 1999 | 2.39% | 1.88% | 0.60x | 2.13x | $-244.12 Million |
| 2000 | -10.33% | -10.55% | 0.47x | 2.09x | $-716.89 Million |
| 2001 | -5.04% | -5.89% | 0.43x | 2.00x | $-570.92 Million |
| 2002 | 0.00% | -13.26% | 0.78x | 0.00x | $-413.92 Million |
| 2003 | 0.00% | -10.98% | 0.94x | 0.00x | $-360.81 Million |
| 2004 | 0.00% | -10.98% | 0.94x | 0.00x | $-338.17 Million |
| 2005 | 0.00% | -25.47% | 0.49x | 0.00x | $-291.93 Million |
| 2006 | 0.00% | -36.52% | 0.51x | 0.00x | $-406.54 Million |
| 2007 | 0.00% | 37.61% | 0.85x | 0.00x | $808.85 Million |
| 2008 | 0.00% | 13.80% | 0.92x | 0.00x | $369.34 Million |
| 2009 | 0.00% | 4.96% | 1.14x | 0.00x | $192.20 Million |
| 2010 | 0.00% | 48.30% | 0.78x | 0.00x | $907.52 Million |
| 2011 | 178.38% | 10.40% | 0.88x | 19.41x | $197.00 Million |
| 2012 | 29.19% | 8.67% | 0.88x | 3.82x | $121.62 Million |
| 2013 | 73.92% | 14.40% | 0.89x | 5.79x | $279.82 Million |
| 2014 | 39.19% | 9.35% | 0.70x | 6.02x | $165.36 Million |
| 2015 | 29.95% | 5.88% | 0.68x | 7.53x | $121.96 Million |
| 2016 | 33.65% | 6.80% | 0.78x | 6.36x | $174.01 Million |
| 2017 | 22.94% | 6.93% | 0.80x | 4.14x | $152.93 Million |
| 2018 | 21.99% | 6.83% | 0.82x | 3.93x | $159.39 Million |
| 2019 | 26.53% | 7.79% | 0.76x | 4.50x | $223.48 Million |
| 2020 | 17.90% | 7.97% | 0.55x | 4.06x | $125.40 Million |
| 2021 | 21.57% | 10.27% | 0.58x | 3.59x | $221.07 Million |
| 2022 | 20.68% | 6.23% | 0.77x | 4.30x | $139.97 Million |
| 2023 | 21.37% | 7.33% | 0.79x | 3.70x | $187.25 Million |
| 2024 | 22.05% | 8.48% | 0.82x | 3.16x | $249.00 Million |
| 2025 | 23.22% | 9.54% | 0.84x | 2.91x | $322.38 Million |
Industry Comparison
This section compares Encompass Health Corp's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $637,078,629
- Average return on equity (ROE) among peers: -7.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Encompass Health Corp (EHC) | $3.37 Billion | 0.00% | 1.17x | $10.07 Billion |
| Acadia Healthcare Company Inc (ACHC) | $2.51 Billion | 4.35% | 1.75x | $1.52 Billion |
| Addus HomeCare Corporation (ADUS) | $175.08 Million | 7.77% | 0.53x | $1.69 Billion |
| agilon health Inc (AGL) | $1.04 Billion | -10.24% | 0.63x | $264.44 Million |
| Airsculpt Technologies Inc (AIRS) | $120.39 Million | -1.84% | 0.42x | $377.42 Million |
| Amedisys Inc (AMED) | $4.30 Million | 20.93% | 1.67x | $3.32 Billion |
| AMN Healthcare Services Inc (AMN) | $736.74 Million | 15.47% | 1.62x | $624.22 Million |
| American Shared Hospital Service (AMS) | $24.05 Million | -1.30% | 1.98x | $8.87 Million |
| American Oncology Network Inc. (AONC) | $70.71 Million | -7.84% | 4.30x | $292.48 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.68 Billion | 8.06% | 2.14x | $1.34 Billion |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.90 Billion |
About Encompass Health Corp
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary servic… Read more